Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-11-14
2006-11-14
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S428000
Reexamination Certificate
active
07135494
ABSTRACT:
The invention provides a compound of formula (I). This invention relates to heterocyclic compounds. It further relates to methods for their preparation, compositions cotaining them and their use as a medicament, particularly as a medicament for the treatment and prophylaxis of cancer.
REFERENCES:
patent: 3-31257 (1991-02-01), None
patent: 08 157475 (1996-06-01), None
patent: WO 92/21660 (1992-12-01), None
Boogaard, A. et al. Ring D Modifications of Ellipticine, Part 2. Chlorination of Ellipticine via its N-oxide and Syntheses and Selective Acetylation of 5, 6, 11-Trimethyl-5H-Benzo[b]Carbazole. Tetrahedron. 50:16, pp. 4811-4828 (1994).
Dalton L. et al. Synthesis of the Tumour-Inhibitory Alkaloids, Ellipticine, 9-Methoxyellipticine, and Related Pyrido (4,3-b) Carbazoles. Australian Journal of Chemistry. 20:12, pp. 2715-2727 (Dec. 1967).
Faircloth, G. et al. A Simple Screening Procedure for the Quantitative Measurements of Cytotoxicity to Resting Primary Lymphocyte Cultures. Journal of Tissue Culture Methods. 11:4, pp. 201-205 (1988).
Kaneda, M. et al. Carbazomycins G and H, Novel Carbazomycin-Congeners Containing a Quinol Moiety. J. of Antibiotics. XLI:5, pp. 602-608 (May 1988).
Knolker, H. et al. Transition Metal Complexes in Organic Synthesis, Part 38. Tetrahedron Letters. 38, 23, pp. 4051-5054 (1997).
Monks, A. et al. Feasibility of a high flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J.Natl.Cancer Inst. 83, pp. 757-766 (1991).
Mosmann. T. Rapid Colorimetric Assay for Cellular Growth and Survival: Application to Proliferation and Cytotoxicity Assays. Journal Immunological Methods. 65:1-2, pp. 55-63 (1983).
Skehan, P. et al. New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening. Journal of the National Cancer Institute. 82:13, pp. 1107-1112 (Jul. 4, 1990).
Sundberg, R. Five-Membered Ring Systems: Pyrroles and Benzo Derivatives. Heterocyclic Chemistry, vol. 4, pp. 81-94 (1992).
Svoboda, G. et al. Alkaloids of Ochrosia maculate Jacq. (Ochrosia borbonica Gmel.). J. of Pharmaceutical Sciences. 57:10, pp. 1720-1725 (Oct. 1968).
Database Chemabs. Somei, M. Preparation of 1-Hydroxyindole Derivatives as Blood Platelet Aggregation Inhibitors. STN Database accession No. 125:195426, XP002192741, RN:161203-02-7.
Database Chemabs, Sundberg, R. Five-membered Ring Systems. Database accession No. 119:180607, XP002194742. RM54989-33-2.
Database Chemabs. Somei, M. Preparation of Indole Derivatives. Database accession No. 114:247138, CP002192743, RN:125812-48-8, RN:125812-49-9.
Database Chemabs. Zherebtsov, I. Chromatographic Determiantion of Carbazole and its Derivatives. Database accession No. 97:49034, XP002192744, RN: 8234-70-6.
International Search Report PCT/GB 01/05523, Mar. 5, 2002.
Russian language version of Zherbtsov, I. P., et al, “Chromatographic Determination of Carbazole and its Derivatives.” Publication Source: Deposited Doc. (1980), SPSTL 641khp-D80.
Blunt John Wilson
Garcia Gravalos Dolores
Munro Murray Herbert Gibson
Urban Sylvia
Pharma Mar S.A.
Saeed Kamal A.
Shiao Robert
LandOfFree
Antitumoral carbazoles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antitumoral carbazoles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antitumoral carbazoles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3702704